Biomarker & Intervention Discovery

Asthma

Pharmacologically actionable gene targets, therapeutic agents ranked by evidence tier, and active clinical trials.

US DALYs1.44MWHO GHE 2021 · all ages
Global DALYs21.99MWHO GHE 2021 · worldwide
US mortality3,646 deaths/yrWHO GHE 2021
Global mortality425.7K deaths/yrWHO GHE 2021 · worldwide
NIH funding$242MFY2025 · RCDC estimate
Funding levelUnderfunded
Spontaneous remission26% of childhood-onset asthma in clinical remission by adulthood; <20% adult-onset achieves sustained remission; 65%…
Best-intervention remissionBiologics (anti-IL-5, anti-IL-4/13, anti-IgE) achieve near-zero exacerbation rates in eligible severe patients…
Gap sizeModerate; highly severity-dependent; large practice gap for AIT
Primary barrierbiological (severe phenotype) + practice (AIT underutilized)
Full remission profile →
Research Tracker / Chronic Disease Interventions / Asthma / Biomarker Atlas →

Remission & chronicity

Spontaneous remission
26% of childhood-onset asthma in clinical remission by adulthood; <20% adult-onset achieves sustained remission; 65% long-term remission in mild-moderate vs 16% in severe
Best-intervention remission
Biologics (anti-IL-5, anti-IL-4/13, anti-IgE) achieve near-zero exacerbation rates in eligible severe patients; allergen immunotherapy (AIT) achieves sustained drug-free remission in allergic asthma in ~30-40% of treated patients
Gap size
Moderate; highly severity-dependent; large practice gap for AIT
Primary barrier
biological (severe phenotype) + practice (AIT underutilized)
Allergen immunotherapy is the only disease-modifying treatment for allergic asthma and is underused relative to guidelines; biological phenotyping (T2-high vs T2-low) drives outcomes more than treatment intensity alone
Biomarker Targets & Therapeutic Agents

Gene targets queried against DGIdb, Open Targets, ChEMBL, PubMed, and Europe PMC. Agents ranked: ● Clinical > ● Mechanistic > ● Correlative.

ADRB2 148ALOX5 181CYSLTR1 189FCER1A 17GATA3 19IL13 11IL13RA1 2IL1RL1 1IL33 6IL4 4IL4R 6IL5 9IL5RA 1MS4A2 31TSLP 2

ADRB2

UniProt Ensembl DGIdb Open Targets
Therapeutic Agent Effect Direction Evidence Tier Potency Source
CARVEDILOL ↓ inhibits Mechanistic DGIdb
CHEMBL:CHEMBL1257092 ? unclear Mechanistic DGIdb
SODIUM CHLORIDE ? unclear Mechanistic DGIdb
PENBUTOLOL SULFATE ↓ inhibits Mechanistic DGIdb
DESIPRAMINE ? unclear Mechanistic DGIdb
METIPRANOLOL ? unclear Mechanistic DGIdb
CHEMBL:CHEMBL531322 ? unclear Mechanistic DGIdb
NADOLOL ↓ inhibits Mechanistic DGIdb
PIRBUTEROL ? unclear Mechanistic DGIdb
FENOTEROL ↑ activates Mechanistic DGIdb
TIMOLOL ↓ inhibits Mechanistic DGIdb
ABEDITEROL ↑ activates Mechanistic DGIdb
PINDOLOL ↑ activates Mechanistic DGIdb
BRONCHODILATOR ? unclear Mechanistic DGIdb
TULOBUTEROL ↑ activates Mechanistic DGIdb
PHENYLEPHRINE HYDROCHLORIDE ? unclear Mechanistic DGIdb
GSK159802 ↑ activates Mechanistic DGIdb
PRILOCAINE HYDROCHLORIDE ? unclear Mechanistic DGIdb
CLENBUTEROL ↑ activates Mechanistic DGIdb
PROPRANOLOL HYDROCHLORIDE ↓ inhibits Mechanistic DGIdb
INDACATEROL MALEATE ↑ activates Mechanistic DGIdb
VILANTEROL ? unclear Mechanistic DGIdb
TERTATOLOL ? unclear Mechanistic DGIdb
ARFORMOTEROL ↑ activates Mechanistic DGIdb
INDACATEROL ? unclear Mechanistic DGIdb
FORMOTEROL FUMARATE ↑ activates Mechanistic DGIdb
CHEMBL:CHEMBL111201 ? unclear Mechanistic DGIdb
RITODRINE ? unclear Mechanistic DGIdb
RISPERIDONE ? unclear Mechanistic DGIdb
CHEMBL:CHEMBL599896 ? unclear Mechanistic DGIdb
VILANTEROL TRIFENATATE ↑ activates Mechanistic DGIdb
RITODRINE HYDROCHLORIDE ↑ activates Mechanistic DGIdb
DISULFIRAM ? unclear Mechanistic DGIdb
BUCINDOLOL HYDROCHLORIDE ↓ inhibits Mechanistic DGIdb
LEVALBUTEROL TARTRATE ↑ activates Mechanistic DGIdb
LAS190792 ↑ activates Mechanistic DGIdb
ALPRENOLOL ? unclear Mechanistic DGIdb
CELIPROLOL ↑ activates Mechanistic DGIdb
ALBUTEROL SULFATE ↑ activates Mechanistic DGIdb
CARTEOLOL ? unclear Mechanistic DGIdb

Showing top 40 of 148 agents ranked by evidence tier.

ALOX5

UniProt Ensembl DGIdb Open Targets
Therapeutic Agent Effect Direction Evidence Tier Potency Source
BALSALAZIDE ? unclear Mechanistic DGIdb
MASOPROCOL ? unclear Mechanistic DGIdb
DARBUFELONE ? unclear Mechanistic DGIdb
MECLOFENAMATE ? unclear Mechanistic DGIdb
CGP 47656 ↑ activates Mechanistic DGIdb
TEPOXALIN ↓ inhibits Mechanistic DGIdb
MESALAMINE ↓ inhibits Mechanistic DGIdb
CHEMBL:CHEMBL416038 ? unclear Mechanistic DGIdb
PF-4191834 ↓ inhibits Mechanistic DGIdb
PTC299 ? unclear Mechanistic DGIdb
MELATONIN ? unclear Mechanistic DGIdb
MECLOFENAMATE SODIUM ↓ inhibits Mechanistic DGIdb
THERAPEUTIC GLUCOCORTICOID ? unclear Mechanistic DGIdb
MONTELUKAST SODIUM ? unclear Mechanistic DGIdb
BALSALAZIDE DISODIUM ↓ inhibits Mechanistic DGIdb
LESOGABERAN ↑ activates Mechanistic DGIdb
ATRELEUTON ? unclear Mechanistic DGIdb
RILOPIROX ? unclear Mechanistic DGIdb
6BIO ? unclear Mechanistic DGIdb
ZILEUTON ↓ inhibits Mechanistic 3300.0 nM (IC50) DGIdb
CHEMBL:CHEMBL502496 ? unclear Mechanistic DGIdb
TENIDAP ? unclear Mechanistic DGIdb
SULFASALAZINE ↓ inhibits Mechanistic DGIdb
DIETHYLCARBAMAZINE ? unclear Mechanistic DGIdb
SELENIUM ? unclear Mechanistic DGIdb
OLSALAZINE SODIUM ↓ inhibits Mechanistic DGIdb
ACACETIN ? unclear Mechanistic DGIdb
LICOFELONE ? unclear Mechanistic DGIdb
TIPELUKAST ? unclear Mechanistic DGIdb
5-OXO-ETE ? unclear Mechanistic DGIdb
METHOTREXATE ? unclear Mechanistic DGIdb
SILYMARIN ? unclear Mechanistic DGIdb
ANACARDIC ACID ? unclear Mechanistic DGIdb
MECLOFENAMIC ACID ? unclear Mechanistic Open Targets
OLSALAZINE ? unclear Mechanistic Open Targets
CHEMBL26083 ↓ inhibits Mechanistic 2500.0 nM (IC50) ChEMBL
CHEMBL25790 ↓ inhibits Mechanistic 6000.0 nM (IC50) ChEMBL
CHEMBL38172 ↓ inhibits Mechanistic 90.0 nM (IC50) ChEMBL
CHEMBL444315 ↓ inhibits Mechanistic 30.0 nM (IC50) ChEMBL
CHEMBL29874 ↓ inhibits Mechanistic 39000.0 nM (IC50) ChEMBL

Showing top 40 of 181 agents ranked by evidence tier.

CYSLTR1

UniProt Ensembl DGIdb Open Targets
Therapeutic Agent Effect Direction Evidence Tier Potency Source
PRANLUKAST ↓ inhibits Mechanistic 0.8 nM (IC50) DGIdb
NEDOCROMIL ? unclear Mechanistic DGIdb
CR-3465 ↓ inhibits Mechanistic DGIdb
CINALUKAST ? unclear Mechanistic DGIdb
CHEMBL:CHEMBL314115 ? unclear Mechanistic DGIdb
RECOMBINANT TRANSFORMING GROWTH FACTOR-BETA 1 ? unclear Mechanistic DGIdb
MASILUKAST ? unclear Mechanistic DGIdb
LY-2300559 ? unclear Mechanistic DGIdb
ZAFIRLUKAST ↓ inhibits Mechanistic 1.731 nM (IC50) DGIdb
MONTELUKAST SODIUM ↓ inhibits Mechanistic DGIdb
IRALUKAST ? unclear Mechanistic DGIdb
MONTELUKAST ? unclear Mechanistic 0.5 nM (IC50) Open Targets
SR-2640 ↓ inhibits Mechanistic 23.0 nM (IC50) ChEMBL
CHEMBL89340 ↓ inhibits Mechanistic 3.1 nM (IC50) ChEMBL
ABLUKAST ↓ inhibits Mechanistic 4000.0 nM (IC50) ChEMBL
FPL-55712 ↓ inhibits Mechanistic 4000.0 nM (IC50) ChEMBL
CHEMBL89768 ↓ inhibits Mechanistic 3.1 nM (IC50) ChEMBL
VERLUKAST ↓ inhibits Mechanistic 8.0 nM (IC50) ChEMBL
POBILUKAST ↓ inhibits Mechanistic 10.0 nM (Ki) ChEMBL
CHEMBL97356 ↓ inhibits Mechanistic 11.0 nM (Ki) ChEMBL
CHEMBL313177 ↓ inhibits Mechanistic 6.42 nM (IC50) ChEMBL
CHEMBL316170 ↓ inhibits Mechanistic 1.06 nM (IC50) ChEMBL
CHEMBL82790 ↓ inhibits Mechanistic 4.7 nM (IC50) ChEMBL
CHEMBL84707 ↓ inhibits Mechanistic 1.91 nM (IC50) ChEMBL
CHEMBL86264 ↓ inhibits Mechanistic 8.49 nM (IC50) ChEMBL
CHEMBL87528 ↓ inhibits Mechanistic 3.36 nM (IC50) ChEMBL
CHEMBL314340 ↓ inhibits Mechanistic 1.16 nM (IC50) ChEMBL
CHEMBL314237 ↓ inhibits Mechanistic 0.76 nM (IC50) ChEMBL
CHEMBL83233 ↓ inhibits Mechanistic 15.7 nM (IC50) ChEMBL
CHEMBL86063 ↓ inhibits Mechanistic 0.72 nM (IC50) ChEMBL
CHEMBL86302 ↓ inhibits Mechanistic 1.63 nM (IC50) ChEMBL
CHEMBL313195 ↓ inhibits Mechanistic 0.47 nM (IC50) ChEMBL
CHEMBL85572 ↓ inhibits Mechanistic 2.43 nM (IC50) ChEMBL
CHEMBL85633 ↓ inhibits Mechanistic 2.01 nM (IC50) ChEMBL
CHEMBL84841 ↓ inhibits Mechanistic 8.67 nM (IC50) ChEMBL
CHEMBL313187 ↓ inhibits Mechanistic 0.38 nM (IC50) ChEMBL
CHEMBL414885 ↓ inhibits Mechanistic 0.65 nM (IC50) ChEMBL
CHEMBL87696 ↓ inhibits Mechanistic 2.16 nM (IC50) ChEMBL
CHEMBL87337 ↓ inhibits Mechanistic 0.55 nM (IC50) ChEMBL
CHEMBL315973 ↓ inhibits Mechanistic 1.05 nM (IC50) ChEMBL

Showing top 40 of 189 agents ranked by evidence tier.

FCER1A

UniProt Ensembl DGIdb Open Targets
Therapeutic Agent Effect Direction Evidence Tier Potency Source
BENZYLPENICILLOYL POLYLYSINE ? unclear Mechanistic DGIdb
COMPOUND 27D [PMID: 28231433] ↓ inhibits Mechanistic DGIdb
OPAGANIB ↓ inhibits Mechanistic DGIdb
PF-543 ↓ inhibits Mechanistic DGIdb
SKI II ↓ inhibits Mechanistic DGIdb
ROME ↓ inhibits Mechanistic DGIdb
MP-A08 ↓ inhibits Mechanistic DGIdb
COMPOUND 55 [PMID: 30889352] ↓ inhibits Mechanistic DGIdb
COMPOUND 49 [PMID: 30889352] ↓ inhibits Mechanistic DGIdb
OMALIZUMAB ? unclear Mechanistic DGIdb
SLC4101431 ↓ inhibits Mechanistic DGIdb
COMPOUND 60 [PMID: 30889352] ↓ inhibits Mechanistic DGIdb
SLM6071469 ↓ inhibits Mechanistic DGIdb
COMPOUND 59 [PMID: 30889352] ↓ inhibits Mechanistic DGIdb
CHEMBL275575 ↓ inhibits Mechanistic 71000.0 nM (IC50) ChEMBL
CHEMBL412391 ↓ inhibits Mechanistic 25000.0 nM (IC50) ChEMBL
CHEMBL267118 ↓ inhibits Mechanistic 82000.0 nM (IC50) ChEMBL

GATA3

UniProt Ensembl DGIdb Open Targets
Therapeutic Agent Effect Direction Evidence Tier Potency Source
PREDNISOLONE ? unclear Mechanistic DGIdb
DEXAMETHASONE ? unclear Mechanistic DGIdb
METHOTREXATE ? unclear Mechanistic DGIdb
ASPARAGINASE ? unclear Mechanistic DGIdb
RIBAVIRIN ↓ inhibits Mechanistic DGIdb
MYCOPHENOLATE MOFETIL ↓ inhibits Mechanistic DGIdb
PEGASPARGASE ? unclear Mechanistic DGIdb
MYCOPHENOLATE ↓ inhibits Mechanistic DGIdb
CYCLOPHOSPHAMIDE ANHYDROUS ? unclear Mechanistic DGIdb
VINCRISTINE ? unclear Mechanistic DGIdb
CYTARABINE ? unclear Mechanistic DGIdb
PREDNISONE ? unclear Mechanistic DGIdb
LEUCOVORIN CALCIUM ? unclear Mechanistic DGIdb
DOXORUBICIN HYDROCHLORIDE ? unclear Mechanistic DGIdb
THIOGUANINE ↓ inhibits Mechanistic DGIdb
MERIMEPODIB ↓ inhibits Mechanistic DGIdb
GLUCARPIDASE ? unclear Mechanistic DGIdb
DAUNORUBICIN LIPOSOMAL ? unclear Mechanistic DGIdb
MERCAPTOPURINE ? unclear Mechanistic DGIdb

IL13

UniProt Ensembl DGIdb Open Targets
Therapeutic Agent Effect Direction Evidence Tier Potency Source
DECTREKUMAB ? unclear Mechanistic DGIdb
TRALOKINUMAB ↓ inhibits Mechanistic DGIdb
QAX-576 ↓ inhibits Mechanistic DGIdb
ROMILKIMAB ↓ inhibits Mechanistic DGIdb
CENDAKIMAB ↓ inhibits Mechanistic DGIdb
ADALIMUMAB ? unclear Mechanistic DGIdb
TNX-650 ↓ inhibits Mechanistic DGIdb
USTEKINUMAB ? unclear Mechanistic DGIdb
LEBRIKIZUMAB ↓ inhibits Mechanistic DGIdb
CNTO-5825 ↓ inhibits Mechanistic DGIdb
ANRUKINZUMAB ↓ inhibits Mechanistic DGIdb

IL13RA1

UniProt Ensembl DGIdb Open Targets
Therapeutic Agent Effect Direction Evidence Tier Potency Source
CINTREDEKIN BESUDOTOX ~ modulates Mechanistic DGIdb
EBLASAKIMAB ? unclear Mechanistic DGIdb

IL1RL1

UniProt Ensembl DGIdb Open Targets
Therapeutic Agent Effect Direction Evidence Tier Potency Source
ASTEGOLIMAB ↓ inhibits Mechanistic DGIdb

IL33

UniProt Ensembl DGIdb Open Targets
Therapeutic Agent Effect Direction Evidence Tier Potency Source
ASTEGOLIMAB ? unclear Mechanistic DGIdb
TORUDOKIMAB ↓ inhibits Mechanistic DGIdb
ETOKIMAB ~ modulates Mechanistic DGIdb
ITEPEKIMAB ↓ inhibits Mechanistic DGIdb
CHEMBL5270750 ↓ inhibits Mechanistic 43000.0 nM (IC50) ChEMBL
CHEMBL5276831 ↓ inhibits Mechanistic 42000.0 nM (IC50) ChEMBL

IL4

UniProt Ensembl DGIdb Open Targets
Therapeutic Agent Effect Direction Evidence Tier Potency Source
PASCOLIZUMAB ↓ inhibits Mechanistic DGIdb
TEPOXALIN ? unclear Mechanistic DGIdb
ROMILKIMAB ↓ inhibits Mechanistic DGIdb
ASPIRIN ? unclear Mechanistic DGIdb

IL4R

UniProt Ensembl DGIdb Open Targets
Therapeutic Agent Effect Direction Evidence Tier Potency Source
SUNITINIB ? unclear Mechanistic DGIdb
CINTREDEKIN BESUDOTOX ~ modulates Mechanistic DGIdb
PITRAKINRA ? unclear Mechanistic DGIdb
DUPILUMAB ↓ inhibits Mechanistic DGIdb
BIZAXOFUSP ? unclear Mechanistic DGIdb
ROMILKIMAB ? unclear Mechanistic DGIdb

IL5

UniProt Ensembl DGIdb Open Targets
Therapeutic Agent Effect Direction Evidence Tier Potency Source
METHYLPREDNISOLONE ? unclear Mechanistic DGIdb
ADENOVIRUS VECTOR ? unclear Mechanistic DGIdb
BENRALIZUMAB ? unclear Mechanistic DGIdb
RESLIZUMAB ↓ inhibits Mechanistic DGIdb
DEPEMOKIMAB ↓ inhibits Mechanistic DGIdb
CYCLOPHOSPHAMIDE ANHYDROUS ? unclear Mechanistic DGIdb
INTERLEUKIN-3 ? unclear Mechanistic DGIdb
CYCLOSPORINE ? unclear Mechanistic DGIdb
MEPOLIZUMAB ↓ inhibits Mechanistic DGIdb

IL5RA

UniProt Ensembl DGIdb Open Targets
Therapeutic Agent Effect Direction Evidence Tier Potency Source
BENRALIZUMAB ↓ inhibits Mechanistic DGIdb

MS4A2

UniProt Ensembl DGIdb Open Targets
Therapeutic Agent Effect Direction Evidence Tier Potency Source
TIRBANIBULIN ↓ inhibits Mechanistic DGIdb
CCT196969 ↓ inhibits Mechanistic DGIdb
N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE ↓ inhibits Mechanistic DGIdb
KX2-361 ↓ inhibits Mechanistic DGIdb
(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE ↓ inhibits Mechanistic DGIdb
PD166285 ↓ inhibits Mechanistic DGIdb
COMPOUND 36 [PMID: 21958547] ↓ inhibits Mechanistic DGIdb
GEMCITABINE ? unclear Mechanistic DGIdb
COMPOUND 25 [PMID: 31260299] ↓ inhibits Mechanistic DGIdb
ELZOVANTINIB ↓ inhibits Mechanistic DGIdb
SYK INHIBITOR III ↓ inhibits Mechanistic DGIdb
COMPOUND 8H [PMID: 22765894] ↓ inhibits Mechanistic DGIdb
MAX-40279 ↓ inhibits Mechanistic DGIdb
ACALABRUTINIB ↓ inhibits Mechanistic DGIdb
SI306 ↓ inhibits Mechanistic DGIdb
COMPOUND 19A [PMID: 30503936] ↓ inhibits Mechanistic DGIdb
NG-25 ↓ inhibits Mechanistic DGIdb
DASATINIB ANHYDROUS ↓ inhibits Mechanistic DGIdb
ECF506 ↓ inhibits Mechanistic DGIdb
CCT241161 ↓ inhibits Mechanistic DGIdb
COMPOUND 2 [PMID: 15546730] ↓ inhibits Mechanistic DGIdb
PP-121 ↓ inhibits Mechanistic DGIdb
SARACATINIB ↓ inhibits Mechanistic DGIdb
BOSUTINIB ↓ inhibits Mechanistic DGIdb
DORSOMORPHIN ↓ inhibits Mechanistic DGIdb
BALAMAPIMOD ↓ inhibits Mechanistic DGIdb
IBRUTINIB ↓ inhibits Mechanistic DGIdb
TAK-020 ↓ inhibits Mechanistic DGIdb
ENMD-2076 ↓ inhibits Mechanistic DGIdb
WH-4-023 ↓ inhibits Mechanistic DGIdb
OMALIZUMAB ? unclear Mechanistic DGIdb

TSLP

UniProt Ensembl DGIdb Open Targets
Therapeutic Agent Effect Direction Evidence Tier Potency Source
TEZEPELUMAB ↓ inhibits Mechanistic DGIdb
AMG-157 ↓ inhibits Mechanistic DGIdb
Clinical Trials

Recruiting and recently completed trials from ClinicalTrials.gov. Data retrieved 2026-07-06.

No recent clinical trials found on ClinicalTrials.gov for this condition.

Agents Found By Disease-Level Search

Searched directly from “Asthma” via ClinicalTrials.gov interventions and Open Targets' disease→drug data — independent of the 15-gene target panel above. This surfaces agents whose mechanism doesn't route through a curated gene (combination therapies, standard-of-care drugs, targets outside the panel).

60 agents shown (approved or with trial evidence) — 57 not found by the gene-target search above.

Mometasone furoateNOT in gene-target list

Approved · 2 trials · source: ClinicalTrials.gov, Open Targets
NCT00835094 NCT00835094

Fluticasone propionateNOT in gene-target list

Approved · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT01159912

Fluticasone furoateNOT in gene-target list

Approved · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT01159912

SpirivaNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02489981

Fixed combination of budesonide and formoterolNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01676987

BudesonideNOT in gene-target list

Approved · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT01676987

Formoterol fumerateNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00460577

fenoterol/ipratropium bromideNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00460577

budesonide/formoterol TurbuhalerNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00235911

CM310NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT05761028

AMAZE™ ApplicationNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT04868500

AMAZE™ DashboardNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT04868500

CHF5993 pMDI with HFA-152aNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT07301736

CHF5993 pMDI with HFA-134aNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT07301736

CHF718 pMDI with HFA-134aNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT07301736

IBI3002NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06213844

SB010NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01470911

Educational Video and Question Prompt ListNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02498834

SHARP programNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01625364

Open Airways for SchoolsNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01625364

OXIMAXNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00975741

ASMANEX TWISTHALERNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00975741

IgE adsorberNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02096237

Administration of inhaled tiotropium bromideNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00557700

Administration of placeboNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00557700

Formoterol Fumarate

Approved · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT00215371

HEPA Air CleanerNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00006565

Placebo Filtration UnitNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00006565

Single Inhalation techniqueNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT05428956

Tidal inhalation techniqueNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT05428956

Postcard and IVR Reminder GroupNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01852656

Postcard Only Reminder GroupNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01852656

IVR Only Reminder GroupNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01852656

AlfacalcidolNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02747381

AER 001NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00535028

Smart inhalerNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT04810169

PEF Interventional SessionNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06612294

Control SessionsNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06612294

Control BoosterNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06612294

Active boosterNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06612294

Clinical Center Reference Endotoxin (CCRE)NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT03623022

Normal salineNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT03623022

SHR-1703 InjectionNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06441812

BENRALIZUMAB

Approved · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT04742504

QVM149NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT03158311

Salmeterol/fluticasone plus tiotropiumNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT03158311

Ginger ExtractNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT03705832

Resistive Flexibility and Strength TrainingNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02370004

Halotherapy (Salt Therapy)NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06250452

Prick testsNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT07402200

Portable sensorsNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT07402200

FP 100NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01156792

GSK2190915 100NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01156792

GSK2190915 300NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01156792

montelukast

Approved · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT01156792

FP/SAL 100/50NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01156792

Use of smart inhaler to enhance asthma inhaler proficiencyNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06783101

Residential mechanical ventilation system (Exhaust)NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06098287

Residential mechanical ventilation system (CFIS) and air filtration upgradesNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06098287

Residential mechanical ventilation system (ERV) and air filtration upgradesNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06098287

Part of the Open Source Medicine Foundation Network

Open Source Medicine Foundation The OSMF hub — advancing open-source biomedical research infrastructure, tools, and evidence synthesis.
SpikeProtein.site Database and research resource on SARS-CoV-2 spike protein biology, persistence, and clinical implications.
Vaccine Data Navigator Open-access navigation tool for vaccine adverse event reporting and surveillance data.
PACVS Research Summit Annual summit convening researchers, clinicians, and patients on PACVS science.